Joseph M. Burnett's Insider Trades & SAST Disclosures
Joseph M. Burnett's most recent trade in ClearPoint Neuro Inc was a trade of 42,414 Common Stock done . Disclosure was reported to the exchange on March 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Joseph M. Burnett.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 42,414 | 313,537 (2%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2025 | 42,414 | 169,657 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.18 per share. | 12 Mar 2025 | 23,405 | 290,132 (1%) | 0% | 13.2 | 308,478 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 47,407 | 297,283 (1%) | 0% | - | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2025 | 47,407 | 47,407 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.19 per share. | 06 Mar 2025 | 26,160 | 271,123 (1%) | 0% | 13.2 | 345,050 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 132,841 | 132,841 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 4.53 per share. | 31 Dec 2024 | 251 | 249,876 (1%) | 0% | 4.5 | 1,137 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.26 per share. | 20 Aug 2024 | 3,236 | 249,625 (1%) | 0% | 11.3 | 36,437 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 4.58 per share. | 28 Jun 2024 | 3,500 | 252,861 (1%) | 0% | 4.6 | 16,030 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.74 per share. | 10 Jun 2024 | 14,003 | 249,361 (1%) | 0% | 5.7 | 80,377 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 212,071 | 212,071 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 23,704 | 94,814 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2024 | 23,704 | 274,430 (1%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.24 per share. | 06 Mar 2024 | 11,066 | 263,364 (1%) | 0% | 6.2 | 69,052 | Common Stock |
| ClearPoint Neuro Inc | Joseph Burnett M. | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 29 Dec 2023 | 1,067 | 250,726 (1%) | 0% | 5.8 | 6,157 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.58 per share. | 09 Jul 2023 | 6,122 | 249,659 (1%) | 0% | 6.6 | 40,283 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 6.15 per share. | 30 Jun 2023 | 2,095 | 255,781 (1%) | 0% | 6.1 | 12,884 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.91 per share. | 10 Jun 2023 | 6,952 | 253,686 (1%) | 0% | 6.9 | 48,038 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 118,518 | 118,518 | - | - | Restricted Stock Units | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 39,506 | 39,506 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.24 per share. | 20 Aug 2022 | 1,457 | 260,638 (1%) | 0% | 13.2 | 19,291 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 16.07 per share. | 15 Aug 2022 | 18,867 | 262,095 (1%) | 0% | 16.1 | 303,193 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.02 per share. | 15 Aug 2022 | 7,778 | 280,962 (1%) | 0% | 16.0 | 124,604 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.24 per share. | 09 Jul 2022 | 6,664 | 286,585 (1%) | 0% | 14.2 | 94,895 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 70,113 | 293,249 (1%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 46,742 | 46,742 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 17.98 per share. | 21 Sep 2021 | 9,637 | 231,787 (1%) | 0% | 18.0 | 173,273 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 29,377 | 29,377 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 14,688 | 241,424 (1%) | 0% | 0 | Common Stock | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.70 per share. | 15 Aug 2021 | 7,353 | 226,736 (1%) | 0% | 17.7 | 130,148 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.54 per share. | 09 Jul 2021 | 3,277 | 234,089 (1%) | 0% | 18.5 | 60,756 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 18.57 per share. | 21 Jun 2021 | 25,000 | 237,366 (1%) | 0% | 18.6 | 464,250 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.65 per share. | 07 Nov 2020 | 14,286 | 253,845 (1%) | 0% | 6.7 | 95,002 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.10 per share. | 15 Aug 2020 | 2,491 | 268,131 (1%) | 0% | 4.1 | 10,213 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.00 per share. | 07 Aug 2020 | 5,763 | 270,622 (1%) | 0% | 4 | 23,052 | Common Stock |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 52,356 | 52,356 | - | - | Stock Options (right to buy) | |
| ClearPoint Neuro Inc | Joseph M. Burnett | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 30,864 | 276,385 (1%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges